Methods for diagnosis of sepsis
First Claim
Patent Images
1. A method for treating a subject for sepsis, comprising:
- (a) identifying a human subject as having increased levels of expression of CEACAM1, ZDHHC19, C9orf95, GNA15, BATF, and C3AR1 biomarkers and decreased levels of expression of KIAA1370, TGFBI, MTCH1, RPGRIP1, and HLA-DPB1 biomarkers relative to a time-matched, control subject with non-infectious inflammation; and
(b) administering an antibiotic to the human subject.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods for diagnosis of sepsis are disclosed. In particular, the invention relates to the use of biomarkers for aiding diagnosis, prognosis, and treatment of sepsis, and to a panel of biomarkers that can be used to distinguish sepsis from noninfectious sources of inflammation, such as caused by traumatic injury, surgery, autoimmune disease, thrombosis, or systemic inflammatory response syndrome (SIRS).
5 Citations
6 Claims
-
1. A method for treating a subject for sepsis, comprising:
-
(a) identifying a human subject as having increased levels of expression of CEACAM1, ZDHHC19, C9orf95, GNA15, BATF, and C3AR1 biomarkers and decreased levels of expression of KIAA1370, TGFBI, MTCH1, RPGRIP1, and HLA-DPB1 biomarkers relative to a time-matched, control subject with non-infectious inflammation; and (b) administering an antibiotic to the human subject. - View Dependent Claims (2, 3, 4, 5)
-
-
6. A method for treating a human subject for sepsis, comprising:
-
(a) calculating a sepsis score for the human subject based on individual expression levels of CEACAM1, ZDHHC19, C9orf95, GNA15, BATF, C3AR1, KIAA1370, TGFBI, MTCH1, RPGRIP1, and HLA-DPB1; (b) diagnosing the human subject as having sepsis based on the sepsis score; and (c) administering an antibiotic to the diagnosed human subject.
-
Specification